| Date Filed | Type | Description |
| 03/21/2023 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Granted 40,000 options to buy
@ $4.19, valued at
$167.6k
|
|
| 07/08/2022 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Granted 26,900 options to buy
@ $4.82, valued at
$129.7k
|
|
| 06/16/2022 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Granted 12,004 options to buy
@ $6.67, valued at
$80.1k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
3
| Hemrajani Rekha (CEO) has filed a Form 3 on Jiya Acquisition Corp. |
| 07/21/2020 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Bought 3,000 shares
@ $19, valued at
$57k
|
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 30,000 options to buy
@ $25.64, valued at
$769.2k
|
|
| 04/09/2020 |
4
| Hemrajani Rekha (See Remarks) has filed a Form 4 on Aravive, Inc.|
Txns:
| Disposed/sold 42,750 shares
@ $0 |
|
| 01/09/2020 |
4
| Hemrajani Rekha (President and CEO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 143,000 options
@ $13.77, valued at
$2M
|
|
| 01/09/2020 |
3
| Hemrajani Rekha (President and CEO) has filed a Form 3 on Aravive, Inc. |
| 08/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2019 |
4
| Hemrajani Rekha (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 70,000 options to buy
@ $6.48, valued at
$453.6k
|
|
| 05/03/2019 |
3
| Hemrajani Rekha (Director) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 03/25/2019 |
4
| Hemrajani Rekha (See Remarks) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Granted 400,000 options to buy
@ $11.23, valued at
$4.5M
|
|
| 03/25/2019 |
3
| Hemrajani Rekha (See Remarks) has filed a Form 3 on Arcus Biosciences, Inc. |